Calquence (acalabrutinib) Drug Interactions
A total of 514 drugs are known to interact with Calquence (acalabrutinib).
- 261 major drug interactions
- 253 moderate drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for Calquence (acalabrutinib) and the medicines listed below.
- Aleve (naproxen)
- alfuzosin (Uroxatral)
- allopurinol (Zyloprim, Lopurin, Aloprim)
- Ambien (zolpidem)
- Ativan (lorazepam)
- Blincyto (blinatumomab)
- Celebrex (celecoxib)
- clobetasol topical (Temovate, Clobex, Dermovate, Olux, Impoyz, Clodan, Cormax, Embeline, Clobevate, Olux/Olux-E Kit, Temovate E, Cormax Scalp, Temovate Emollient, Embeline E, Olux-E)
- colchicine (Colcrys, Mitigare, Gloperba)
- Cozaar (losartan)
- cyclobenzaprine (Flexeril, Fexmid, Amrix, Comfort Pac with Cyclobenzaprine)
- fexofenadine (Allegra, Allegra Allergy, Mucinex Allergy, Allegra Hives, Aller-Ease, Allegra ODT)
- hydroxyzine (Vistaril, Atarax, Hyzine, Vistazine, Rezine)
- Imbruvica (ibrutinib)
- indomethacin (Indocin, Indocin SR, Tivorbex, Indocin IV)
- lidocaine / prilocaine topical (Emla, Medolor Pak, Prilovix, Lidopril, Livixil Pak, Anodyne LPT, Emla Anesthetic Disc, DermacinRx Prizopak, Oraqix, Dolotranz, Lidopril XR, Prikaan, Relador Pak Plus, AgonEaze, Venipuncture CPI, Prilovix Plus, Prilolid, Prilovix Lite, LiproZonePak, DermacinRx Empricaine, DermacinRx Prikaan, Leva Set)
- Norvasc (amlodipine)
- Paxil (paroxetine)
- rabeprazole (Aciphex, Aciphex Sprinkle)
- Reglan (metoclopramide)
Calquence (acalabrutinib) alcohol/food interactions
There is 1 alcohol/food interaction with Calquence (acalabrutinib)
Calquence (acalabrutinib) disease interactions
There are 5 disease interactions with Calquence (acalabrutinib) which include:
More about Calquence (acalabrutinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Pricing & Coupons
- En Español
- Drug class: multikinase inhibitors
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
